Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening

PHASE3CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

August 31, 2016

Conditions
SmokingLung Cancer
Interventions
BEHAVIORAL

Telephone Counseling

The TC arm includes a stepped care approach, 3-6 phone sessions, depending on each participant's needs. Within 1-2 days post-T1 assessment, the intervention will begin. Sessions 1-3 (15 min each) will occur approximately weekly over 3-4 weeks, scheduled at participants' convenience and at strategic therapeutic times (e.g., shortly pre/post-quit date). Continuing smokers or newly quit former smokers who would benefit from relapse prevention sessions will receive up to 3 additional sessions, to be completed within 3-4 weeks. The provision of 3-6 sessions is more intensive than several other telephone counseling interventions. A dose response relationship between quitting and number of sessions has been shown in non-volunteer smokers, and based on our pilot data, the investigators expect that a more intensive intervention will be needed for some participants.

BEHAVIORAL

Minimal Treatment

A list of self-help materials (print-, web-, phone-based), the national telephone quitline phone number, and local in person cessation resources will be given to all participants.

Trial Locations (3)

20007

Georgetown University Medical Center, Washington D.C.

01805

Lahey Hospital and Medical Center, Burlington

07601

Hackensack University Medical Center, Hackensack

All Listed Sponsors
collaborator

Prevent Cancer Foundation

OTHER

lead

Georgetown University

OTHER

NCT02267096 - Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening | Biotech Hunter | Biotech Hunter